MiR-218-targeting-Bmi-1 mediates the suppressive effect of 1,6,7-trihydroxyxanthone on liver cancer cells

Wei-Ming Fu,Li-Peng Tang,Xiao Zhu,Ying-Fei Lu,Yan-Ling Zhang,Wayne Yuk-Wai LEE,Hua Wang,Yang Yu,Wei-Cheng Liang,Chun-Hay Ko,Hong-Xi Xu,Hsiang-Fu Kung,Jin-Fang Zhang
DOI: https://doi.org/10.1007/s10495-014-1047-3
2014-01-01
Apoptosis : an international journal on programmed cell death
Abstract:Traditional Chinese medicine is recently emerged as anti-cancer therapy or adjuvant with reduced side-effects and improved quality of life. In the present study, an active ingredient, 1,6,7-trihydroxyxanthone (THA), derived from Goodyera oblongifolia was found to strongly suppress cell growth and induce apoptosis in liver cancer cells. MicroRNAs are a group of small non-coding RNAs that regulate gene expression at post-transcriptional levels. Our results demonstrated that miR-218 was up-regulated and oncogene Bmi-1 was down-regulated by THA treatment. Further investigation showed that THA-induced-miR-218 up-regulation could lead to activation of tumor suppressor P16 Ink4a and P14 ARF , the main down-stream targets of Bmi-1. In conclusion, THA might be a potential anti-cancer drug candidate, at least in part, through the activation of miR-218 and suppression of Bmi-1 expression.
What problem does this paper attempt to address?